Director's Messages

New and Upcoming Opportunities for Alzheimer’s Disease-Related Dementias (ADRD) Research in Fiscal Year 2019

(Saturday, December 1, 2018)
As the US population ages, the burden of illness due to dementia continues to grow at an alarming rate.  This year the US taxpayer, through their representatives in the Congress, have appropriated an additional $425 mi

Honoring Our Inaugural NINDS Landis Mentoring Award Winners in San Diego

(Friday, November 2, 2018)
For so many reasons, I always look forward to the annual meeting of the Society for Neuroscience (SfN), taking place in San Diego this year from November 3-7, 2018.

Now Requesting Your Input: The NIH Blueprint for Neuroscience Research

(Wednesday, October 24, 2018)
Last week, the NIH Blueprint for Neuroscience Research, a group of 14 NIH Institutes, Centers and Offices (ICOs) that support research on the nervous system, released a Request for Information on the Proposed Fundin

NINDS contributions to deep brain stimulation (DBS) and other devices for neurological disorders

(Friday, October 12, 2018)
In our last two updates to highlight NINDS contributions to therapies for neurological disorders, we focused on a recombinant clot-busting protein for acute stroke, enzyme replacement therapies for l

BRAIN 2.0: NIH seeking broad input as it plans the second half of the NIH BRAIN Initiative

(Friday, August 10, 2018)
Researchers funded by the NIH BRAIN Initiative continue to break new ground in scientific discovery and technology development.

Charting the paths to enzyme replacement therapies for lysosomal storage disorders

(Thursday, June 21, 2018)
At the end of January, we launched a new feature on our website that shows how NINDS and the research we support contribute to the discovery and development of treatments for neurologi

The NIH HEAL Initiative and Pain Research

(Tuesday, June 12, 2018)
In last month’s NINDS Director’s message I introduced the planning stages of the NIH HEAL

Making Progress in Glioblastoma

(Wednesday, May 30, 2018)
NINDS Director Walter J. Koroshetz and NCI Director Norman E. Sharpless

The NINDS R35 Program: An innovation experiment

(Tuesday, May 15, 2018)
NIH relies heavily on investigator-initiated R01 grants to fuel its science. This democratic approach is responsible in large part for the success of the American biomedical research enterprise.

The NIH HEAL initiative

(Wednesday, May 2, 2018)
As the Nation’s medical research agency, one of NIH’s most important roles is leveraging our resources to respond to emerging public health crises.